| Literature DB >> 33119788 |
Jalid Sehouli1, Kathrin Heise1, Rolf Richter1, Hannah Woopen1, Louise Anders1, Melisa Guelhan Inci2.
Abstract
PURPOSE: The aim of this study was to investigate preoperative quality of life (QoL) as a predictive tool for severe postoperative complications (POC) in gynecological cancer surgery.Entities:
Keywords: Gynecology; Oncology; Postoperative complications; Quality of life (QoL); Surgery
Mesh:
Year: 2020 PMID: 33119788 PMCID: PMC8604839 DOI: 10.1007/s00404-020-05847-1
Source DB: PubMed Journal: Arch Gynecol Obstet ISSN: 0932-0067 Impact factor: 2.344
Patient characteristics
| Characteristics | |||
|---|---|---|---|
| Clavien–Dindo 0–IIIa | Clavien–Dindo IIIb–V | ||
| Median (range) | Median (range) | ||
| Age (years) | 59 (18–86) | 63 (31–87) | 0.3 |
| BMI (kg/m2) continous | 24.5 (17.5–54.7) | 29.12 (20.6–46.4) | < 0.001 |
| BMI (kg/m2) categorical | 0.001 | ||
| Underweight (< 20) | 23 (12.4) | 0 | |
| Normal (20–25) | 100 (53.8) | 13 (32.5) | |
| Overweight (> 25–30) | 21 (11.3) | 9 (22.5) | |
| Obese (> 30) | 42 (22.6) | 18 (45) | |
| Entities | 0.3 | ||
| Ovarian, fallopian tube, peritoneal cancer | 126 (67.7) | 29 (72.5) | |
| Borderline tumor of the ovary | 5 (2.7) | 0 | |
| Endometrial cancer | 30 (16.1) | 5 (12.5) | |
| Cervical cancer | 16 (8.6) | 6 (15) | |
| Vulvar, vaginal cancer | 9 (4.8) | 0 | |
Functional parameters
| Functional parameter | |||
|---|---|---|---|
| Clavien–Dindo 0–IIIa | Clavien–Dindo IIIb–V | ||
| ASA ≥ 3 | 48 (25.8) | 22 (56.4) | < 0.001 |
| ECOG 2–3 | 9 (4.8) | 10 (25) | < 0.001 |
| Polypharmacy (Amount of co-drugs ≥ 5) | 29 (15.6) | 15 (37.5) | 0.003 |
| Barthel Index < 100 | 15 (8.1) | 12 (30) | < 0.001 |
| IADL < 8 | 7 (3.8) | 7 (17.5) | 0.004 |
| Charlson Comorbidity Index > 2 | 47 (25.3) | 21 (52.5) | 0.001 |
| MMSE < 27 | 4 (2.2) | 3 (7.5) | 0.11 |
| TUG > 9.5 s | 36 (19.4) | 19 (47.5) | < 0.001 |
ASA American Society of Anesthesiologists physical status classification system, ECOG Eastern Cooperative Oncology Group performance status, IADL Instrumental Activities of Daily Living Scale, MMSE Mini Mental State Examination, TUG Timed “Up & Go”
Types and frequency of POC ≥ grade IIIb according to Clavien–Dindo
| Type | ||
|---|---|---|
| % | ||
| Anastomosis insufficiency | 13 | 5.8 |
| Wound infection/dehiscence | 8 | 3.5 |
| Pulmonary embolism | 7 | 3.1 |
| Sepsis | 7 | 3.1 |
| Peritonitis | 5 | 2.2 |
| Intestinal perforation | 4 | 1.8 |
| Acute renal failure | 4 | 1.8 |
| CNS complication | 4 | 1.8 |
| Bowel obstruction | 3 | 1.3 |
| Pneumonia | 1 | 0.4 |
| Bilary leak | 1 | 0.4 |
| Secondary haemorrhage | 1 | 0.4 |
Results univariate analysis
| Characteristics | Unadjusted OR (95% CI) | |
|---|---|---|
| Overall condition | ||
| ASA > 2 | 3.72 (1.82–7.59) | < 0.001 |
| ECOG > 1 | 10.81 (3.62–32.26) | < 0.001 |
| TUG-Test > 9.5 sek | 8.18 (2.58– 25.93) | < 0.001 |
| Barthel Index < 100 | 4.89 (2.07–11.52) | < 0.001 |
| IADL < 8 | 5.36 (1.77– 16.3) | 0.003 |
| Polypharmacy ≥ 5 co-drugs | 3.25 (1.53–6.9) | 0.002 |
| CCI > 2 | 3.27 (1.62–6.6) | 0.001 |
| BMI | ||
| > 25 – < 30 | 6.06 (2.22–16.52) | < 0.001 |
| ≥ 30 | 7.14 (2.65–19.26) | < 0.001 |
| EORTC | ||
| Physical functioning < 70 | 9.18 (3.92–21.48) | < 0.001 |
| Role functioning ≤ 50 | 3.29 (1.61–6.73) | 0.001 |
| Social functioning < 70 | 2.15 (1.06–4.35) | 0.03 |
| Cognitive functioning < 100 | 1.81 (0.91–3.61) | 0.09 |
| Global QoL ≤ 50 | 3.34 (1.63–6.85) | 0.001 |
| Fatigue > 60 | 5.19 (2.47–10.92) | < 0.001 |
| Nausea/vomiting > 20 | 4.77 (2.02–11.26) | < 0.001 |
| Pain > 20 | 3.18 (1.52–6.65) | 0.002 |
| Constipation > 30 | 3.04 (1.44–6.44) | 0.004 |
| Loss of appetite > 50 | 2.37 (1.08–5.22) | 0.03 |
| Sleep disturbances > 50 | 1.90 (0.94–3.84) | 0.07 |
| NCCN DT | ||
| Problems > 10 | 4.48 (2.19–9.16) | < 0.001 |
| Distress score > 5 | 2.63 (1.27–5.43) | 0.01 |
| Symptoms | ||
| Obstipation | 3.63 (1.67–7.92) | 0.001 |
| Nausea/vomiting | 3.47 (1.6–7.52) | 0.002 |
| Bowel obstruction | 7.50 (2.44–23.06) | < 0.001 |
| VNRS > 2 | 1.99 (0.99–3.99) | 0.06 |
| German pelvic questionnaire | ||
| Impaired bowel function > 1 | 3.37 (1.51–7.5) | 0.003 |
| Impaired bladder function > 3.5 | 2.56 (1.23–5.31) | 0.01 |
| Sexual function | 0.91 (0.4–0.59) | 0.5 |
| MMSE < 27 | 3.67 (0.79–17.08) | 0.10 |
ASA American Society of Anesthesiologists physical status classification system, ECOG Eastern Cooperative Oncology Group performance status, TUG-Test Timed "Up and Go"-Test, IADL Instrumental Activities of Daily Living Scale, CCI Charlson Comorbidity Index, BMI Body Mass Index, EORTC European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire, NCCN-DT National Comprehensive Cancer Network Distress Thermometer, VNRS Verbal Numeric Rating Scale for pan, MMSE Mini Mental State Examination
Results of multivariate analysis, gradual logistic regression through all data
| Characteristics | Adjusted OR (95% CI) | |
|---|---|---|
| BMI > 25 | 5.44 (2.04–14.49) | 0.001 |
| EORTC nausea/vomiting > 20 | 3.08 (1.15–8.26) | 0.03 |
| EORTC physical functioning < 70 | 5.08 (2.23–11.59) | < 0.001 |
| MMSE < 27 | 7.94 (1.36–45.46) | 0.02 |
BMI Body Mass Index, EORTC European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire, MMSE Mini Mental State Examination